| Immunotherapy-Based Strategies for the Treatment of Autoimmune Diabetes: Searching for the Cure. | |
| | |
MedLine Citation:
|
PMID: 21864264 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Type 1 Diabetes is an autoimmune disease most often associated with elevated and uncontrolled blood glucose levels. Therefore patient education and treatment compliance is often focused on disease maintenance through insulin treatment and blood glucose control. Unfortunately insulin therapy alone does not prevent the formation of diabetic complications. In order to find a real cure, the underlying pathology of the disease must be directly addressed. Diabetes is caused by the initial rapid destruction of the insulin producing beta cells of the pancreas by autoreactive T-cells. The autoimmune process is also maintained through dendritic cell auto-antigen presentation and the production of autoantibodies by B cells. Only through some forms of immunotherapy can the immune system be rebalanced to assure the survival of the remaining beta cell population. These techniques include cell ablation, competitive decoy auto-antigens, reduced cell activation, and auto-antigen introduction. Here we will review the current state of these different technologies and their progression through clinical trials for the treatment of type 1 diabetes. |
| | |
Authors:
|
Brett E Phillips; Massimo Trucco |
Related Documents
:
|
3098814 - Diabetic ketoacidosis-induced hyperkalemia. prevalence and possible origin. 2127094 - Symptomatic cerebral swelling complicating diabetic ketoacidosis documented by intraven... 7359524 - Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 2.... 16704584 - High concentration potassium permanganate eliminates protein and particle contamination... 7934974 - Evidence for a short-term stimulatory effect of insulin on cholesterol synthesis in new... 8093604 - Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozoc... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-25 |
Journal Detail:
|
Title: Current pharmaceutical design Volume: - ISSN: 1873-4286 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9602487 Medline TA: Curr Pharm Des Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Division of Immunogenetics Children's Hospital of Pittsburgh Rangos Research Center, 4401 Penn Avenue, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anti-TNF treatment in Rheumatoid Arthritis.
Next Document: B Cell Modulation Strategies in Autoimmunity: the SLE Example.